“Lebrikizumab Vs Other Systemic Monotherapies for Moderate to Severe Atopic Dermatitis: Network Meta-Analysis of Short-Term Efficacy”. SKIN The Journal of Cutaneous Medicine 9, no. 1 (January 13, 2025): s517. Accessed May 15, 2026. https://skin.dermsquared.com/skin/article/view/3159.